Benzinga | Nov 9, 2021 11:31AM EST

Amicus Therapeutics Q3 EPS $(0.19) Misses $(0.18) Estimate, Sales $79.50M Miss $80.11M Estimate

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.18) by 5.56 percent. This is a 13.64 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $79.50 million which missed the analyst consensus estimate of $80.11 million by 0.76 percent. This is a 17.89 percent increase over sales of $67.44 million the same period last year.